Multidrug resistance-associated protein expression in clinical gastric carcinoma

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1681-1687

  Endo, Kazuya ^a   Maehara, Yoshihiko ^b   Ichiyoshi, Yuji ^b   Kusumoto, Tetsuya ^a   Sakaguchi, Yoshihisa ^b   Ohno, Shinji ^b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

chemosensitivity; gastric cancer; immunohistochemical staining; multidrug resistance associated protein; p53

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; MITOMYCIN C; PROTEIN; PROTEIN P53;

CANCER INVASION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SENSITIVITY; GASTRECTOMY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029881722     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1681::AID-CNCR39>3.0.CO;2-U     Document Type: Conference Paper

References (39)

1. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Nose Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1992;1:341-6.
2. Maehara Y, Okuyama T, Kakeji Y, Baba H, Furusawa M, Sugimachi K. Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. Am J Surg 1994;168:36-40.
3. Pastan I, Gottesman MM. Multidrug resistance in human cancer. N Engl J Med 1987;316:1388-93.
4. Croop J, Gros P, Housman DE. Genetics of multidrug resistance. J Clin Invest 1988;81:1303-9.
5. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989; 58:137-71.
6. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai S-L, Gazdar A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116-24.
7. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:7160-4.
8. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258:1650-4.
9. Mirski SE, Gerlach JH, Cole SP. Multidrug resistance in a human small cell lung cancer cell line selected in Adriamycin. Cancer Res 1987,47:2594-8.
10. Zaman GJ, Versantvoort CH, Smit JJ, Eijdems EW, de Haas M, Smith AJ, et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993;53:1747-50.
11. Barrand MA, Heppel-Parton AC, Wright KA, Rabbits PH, Twentyman PR. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Natl Cancer Inst 1994;86:110-7.
12. Schneider E, Horton JK, Yang C-H, Nakagawa M, Cowan KH. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 1994;54:152-8.
13. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 1993;53:3658-61.
14. Cole SP, Bhardwaj G, Kurz EU, Deeley RG. A novel ATP-binding cassette transporter gene in multidrug-resistant human lung tumor cells. Proc Am Assoc Cancer Res 1993;34:579.
15. Slovak ML, Ho JP, Bhardwaj G, Kurz EU, Deeley RG, Cole SP. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res 1993;53:3221-5.
16. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992;8:67-113.
17. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994;54:357-61.
18. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, et al. The human multidrug resistance-associated protein (MRP) is a plasma membrane drug efflux pump. Proc Natl Acad Sci USA 1994;91:8822-6.
19. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJ, Scheper RG, et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug resistant tumor cells by monoclonal antibodies. Cancer Res 1994;54:4557-63.
20. O'Connell MJ. Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol 1985;3:1032-9.
21. Haller DG. Chemotherapy in gastrointestinal malignancies. Semin Oncol 1988;15:50-64.
22. Maehara Y, Anai H, Kusumoto H, Sugimachi K. Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma. Eur J Surg Oncol 1987;13:203-6.
23. Kusumoto H, Maehara Y, Yoshida M, Takahashi I, Anai H, Sugimachi K. Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer. Anticancer Drugs 1992;3:33-8.
24. Saito A, Korenaga D, Maehara Y, Baba H, Okumura T, Sugimachi K. In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma-relationship to DNA content. Cancer Chemother Pharmacol 1992;29:185-9.
25. Sakaguchi Y, Anai H, Kohnoe S, Emi Y, Kusumoto T, Maehara Y, et al. Resistance to anticancer drugs of well differentiated gastric adenocarcinoma with venous invasion. Eur J Surg Oncol 1992;18:142-5.
26. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. Part I and Part II. Jpn J Surg 1981;11:127-45.
27. Tasaki Y, Nakagawa M, Ogata J, Kiue A, Tanimura H, Kuwano M, et al. Reversal by a dihydropyridine derivative of non-P-glycoprotein-mediated multidrug resistance in etoposide-resistant human prostatic cancer cell line. J Urol 1995; 154:1210-6.
28. Maehara Y, Kohnoe S, Sugimachi K. Chemosensitivity test for carcinoma of digestive organs. Semin Surg Oncol 1990;6:42-7.
29. Oiwa H, Maehara Y, Ohno S, Sakaguchi Y, Ichiyoshi Y, Sugimachi K. Growth pattern and p53 overexpression in patients with early gastric cancer. Cancer 1995;75:1454-9.
30. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai Y, Maehara Y, et al. Gastric cancer with p53 overexpression has high potential for metastasizing to lymph nodes. Br J Cancer 1993;67:589-93.
31. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936-42.
32. Hipfner DR, Gauldie SD, Deeley RG, Cole SP. Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 1994;54:5788-92.
33. Ota E, Abe Y, Oshika Y, Ozeki Y, Iwasaki M, Inoue H, et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 1995;72:550-4.
34. Clarke AB, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362:849-52.
35. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
36. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994;54:5902-10.
37. Maehara Y, Kusumoto T, Sakaguchi Y, Kusumoto H, Kido Y, Anai H, et al. Pyrimidine nucleotide synthesis is more extensive in poorly differentiated than in well-differentiated human gastric carcinoma. Cancer 1989;63:96-101.
38. Mitsudomi T, Kaneko S, Tateishi M, Yano T, Ishida T, Kohnoe S, et al. Chemosensitivity testing of human lung cancer tissues using the succinate dehydrogenase inhibition test. Anticancer Res 1990;10:987-90.
39. Müller M, Meijer C, Zaman GJ, Borst P, Scheper RJ, Mulder NH, et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 1994;91:13033-7.